NCT05276661

Brief Summary

The aim of the study was to use probiotic beauty products for 4 weeks and evaluate the impact of products on healthy skin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2020

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

March 3, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 11, 2022

Completed
Last Updated

March 11, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

March 3, 2022

Last Update Submit

March 3, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Effects of the TAC/Collagen Gel on Human Skin Hydration

    Corneometer® CM825 was utilized to measure skin moisture. Units: arbitrary Corneometer® units 0-120

    Subjects will be tested in the 4th week

  • Effects of the TAC/Collagen Gel on Human Skin Sebum

    Callegari 1930 was utilized to measure skin inflammation. Units: arbitrary units.

    Subjects will be tested in the 4th week

  • Effects of the TAC/Collagen gel on Human Skin Inflammation

    Chroma Meter MM-500 was utilized to measure skin inflammation. Units: arbitrary units.

    Subjects will be tested in the 4th week

  • Effect of TAC/Collagen Gel on Human Acne Healing and Porphyrins Numbers

    VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units

    Subjects will be tested in the 4th week

  • Effects of the TAC/Collagen Gel on Human Skin Brown Spot Numbers

    VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units

    Subjects will be tested in the 4th week

Study Arms (2)

"A" gel (TAC/Collagen gel)

EXPERIMENTAL

The "A" gel (TAC/Collagen gel) was applied on subjects' right face

Dietary Supplement: TAC/Collagen gel

"B" gel (placebo lotion)

PLACEBO COMPARATOR

the "B" gel (placebo lotion) on their left face

Dietary Supplement: placebo lotion

Interventions

TAC/Collagen gelDIETARY_SUPPLEMENT

Apply it twice per day for 4 weeks

"A" gel (TAC/Collagen gel)
placebo lotionDIETARY_SUPPLEMENT

Apply it twice per day for 4 weeks

"B" gel (placebo lotion)

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy volunteers aged above 20 years old

You may not qualify if:

  • Subject with diseases of the skin, heart, liver, kidney, endocrine and other organs and patients with mental illness (according to medical history).
  • Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
  • Female who is pregnant or nursing or planning to become pregnant during the course of the study.
  • Received facial laser therapy, chemical peeling or UV overexposure in the past 4 weeks.
  • Involuntary subject
  • People who is taking chronic disease medication

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chia Nan University of Pharmacy & Science

Tainan, 71710, Taiwan

Location

MeSH Terms

Conditions

Skin Diseases

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Study Officials

  • Chia-Hua Liang, PhD

    Chia Nan University of Pharmacy & Scienc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2022

First Posted

March 11, 2022

Study Start

May 18, 2020

Primary Completion

August 1, 2020

Study Completion

August 15, 2020

Last Updated

March 11, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations